If you have trouble viewing the newsletter, please click here.

Dear ESOP-members!

In this newsletter we would like to present a review of the ECOP 3 in Dubrovnik and two reports to keep you updated on our activities and to give new impetus to your own daily work:


ECOP 3 Congress in Dubrovnik, May 19-21, 2016

Evaluation: We would be pleased if you could give us a short feedback on the ECOP 3

Webcast: Watch videos and slides of the sessions at ECOP 2016

Winner of the Rally through the exhibition: Manfred Kühne won the voucher for free participation at the 10th Masterclass in Thessaloniki, Greece.

Everyday survival analysis with the help of a custom made Excel Workbook

Survivalof patients andtime to event of interest are of central importance in everyday hematology/oncology clinical practice. Methods needed to summarize and analyze such data are collectively termed survival analysis and usually require commercial statistical packages to be utilized. An interesting and practical article presenting custom made Excel Workbook intended for summarizing and analysis of survival data has been published recently in a peer reviewed journal.


Retinoid therapy in children with neuroblastoma

Neuroblastoma is a type of cancer most common in childhood population.1,2 This type of cancer can start in early forms of nerve cells. It can be found in any part of sympathetic nervous system.3

Moreover, it is the most common cancer in infants and it represents about 6 % of all pediatric tumors. Neuroblastoma is most often diagnosed in children with average age from 1 to 2 years, and very rarely in children older than 10 years. Sometimes, such tumors are possible to be detected by ultrasound before birth. The risk factors for neuroblastoma are the ones commonly typical for any other type of cancer.

If you don't want to recieve any further ESOP Newsletters, please click to unsubscribe.